Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,112.20 -206.04 -1.35%
S&P 500 1,628.93 -22.88 -1.39%
Nasdaq 3,443.20 -38.98 -1.12%
Ticker Volume Price Price Delta
STOXX 50 2,683.98 -16.95 -0.63%
FTSE 100 6,348.82 -25.39 -0.40%
DAX 8,197.08 -32.43 -0.39%
Ticker Volume Price Price Delta
Nikkei 12,979.40 -265.85 -2.01%
Hang Seng 20,986.90 -238.99 -1.13%
S&P/ASX 200 4,800.00 -61.38 -1.26%
  • Fund Type: FCP
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

Carnegie Fund - Medical Sub-Fund

+ Add to Watchlist

CFE4:GR

59.9740 EUR 0.2410 0.40%

As of 03:57:43 ET on 06/19/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Carnegie Fund - Medical Sub-Fund (CFE4)

Open: 59.9740 High - Low: 59.9740 - 59.9740 Primary Exchange: Frankfurt
Volume: 0 52-Week Range: 48.8600 - 63.2360 Beta vs DAX: 0.5691

ETF Chart for CFE4

No chart data available.
  • CFE4:GR 59.9740
  • 1D
  • 1M
  • 1Y
60.2150
Interactive CFE4 Chart

Previous Close

Fund Profile & Information for CFE4

Carnegie Fund - Medical Sub-Fund is an FCP incorporated in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests globally in equities of companies operating in the pharmaceutical, biotechnology and medical technology sectors.

Inception Date: Telephone: 352-40-40-30-1
Managers: ANGELICA FATOUROS
Web Site: www.carnegieam.com

Fundamentals for CFE4

NAV (on 2013-06-19) 60.2200
Assets (M) (on 2013-05-31) 474.4477
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -0.41
Average 52-Week % Premium -0.7172
Fund Leveraged N

Dividends for CFE4

No dividends reported

Performance for CFE4

1-Month -2.80% 1-Year +22.84%
3-Month +2.98% 3-Year +13.30%
Year To Date +16.17% 5-Year -
Expense Ratio -

Top Fund Holdings for CFE4

Filing Date: 05/31/2013
Name Position Value % of Total
Pfizer Inc 1,672,359 36,159,462 7.621%
Roche Holding AG 177,900 34,351,919 7.240%
Gilead Sciences Inc 572,832 24,356,289 5.134%
Novartis AG 424,216 23,618,752 4.978%
Celgene Corp 230,387 22,401,153 4.722%
Merck & Co Inc 556,200 20,278,170 4.274%
UnitedHealth Group Inc 369,300 18,375,330 3.873%
Carnegie Fund V - The Carnegie 108,460 17,824,338 3.757%
Fresenius SE & Co KGaA 189,882 17,334,328 3.654%
DaVita HealthCare Partners Inc 139,000 13,453,203 2.836%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil